American Journal of Ophthalmology
Volume 138, Issue 4 , Pages 547-553 , October 2004

Corneal pharmacokinetics of topically applied azithromycin and clarithromycin

,Accepted 30 April 2004.

References 

  1. Chandra NS , Torres MF , Winthrop KL , et al.  Cluster of Mycobacterium chelonae keratitis cases following laser in-situ keratomileusis . Am J Ophthalmol . 2001;132:819–830
  2. Chung MS , Goldstein MH , Driebe WJ , Schwartz BH . Mycobacterium chelonae keratitis after laser in situ keratomileusis successfully treated with medical therapy and flap removal . Am J Ophthalmol . 2000;129:382–384
  3. Ford JG , Huang AJ , Pflugfelder SC , et al.  Nontuberculous mycobacterial keratitis in South Florida . Ophthalmology . 1998;105:1652–1658
  4. Freitas D , Alvarenga L , Sampaio J , et al.  An outbreak of Mycobacterium chelonae infection after LASIK . Ophthalmology . 2003;110:276–285
  5. Fulcher SF , Fader RC , Rosa RH , Holmes GP . Delayed-onset mycobacterial keratitis after LASIK . Cornea . 2002;21:546–554
  6. Gelender H , Carter HL , Bowman B , et al.  Mycobacterium keratitis after laser in situ keratomileusis . J Refract Surg . 2000;16:191–195
  7. Karp CL , Tuli SS , Yoo SH , et al.  Infectious keratitis after LASIK . Ophthalmology . 2003;110:503–510
  8. Kouyoumdjian GA , Forstot SL , Durairaj VD , Damiano RE . Infectious keratitis after laser refractive surgery . Ophthalmology . 2001;108:1266–1268
  9. Solomon A , Karp CL , Miller D , et al.  Mycobacterium interface keratitis after laser in situ keratomileusis . Ophthalmology . 2001;108:2201–2208
  10. Busin M , Ponzin D , Arffa RC . Mycobacterium chelonae interface infection after endokeratoplasty . Am J Ophthalmol . 2003;135:393–395
  11. Gross RH , Holland GN , Elias SJ , Tuz R . Corneal pharmacokinetics of topical clarithromycin . Invest Ophthalmol Vis Sci . 1995;36:965–968
  12. Helm CJ , Holland GN , Lin R , et al.  Comparison of topical antibiotics for treating Mycobacterium fortuitum keratitis in an animal model . Am J Ophthalmol . 1993;116:700–707
  13. Draize JH , Woodward G , Calvery HO . Methods for the study of irritation and toxicity of substances applied to the skin and mucous membranes . J Pharmacol Exp Toxicol . 1944;82:377–390
  14. Davis JL , Gardner SY , Jones SL , et al.  Pharmacokinetics of azithromycin in foals after i.v. and oral dose and disposition into phagocytes . J Vet Pharmacol Ther . 2002;25:99–9104
  15. Turcinov T , Pepeljnjak S . Azithromycin potency determination: optimal conditions for microbiological diffusion method assay . J Pharm Biomed Anal . 1998;17:903–910
  16. Lauderdale T, Chapin KC, Murray, PR. Reagents. In: Murray PR, Baron EJ, Pfaller MA, et al, editors. Manual of clinical microbiology, 7th ed. Washington, DC: ASM Press, 1999: 1669.
  17. Steigbigel NH. Macrolides and clarithromycin. In: Mandell GL, Douglas RG, Bennett JE, Dolin R, editors, 5th ed. Philadelphia: Churchill Livingstone, 2000:371–374.
  18. Amsden GW . Erythromycin, clarithromycin, and azithromycin: are the differences real? . Clin Ther . 1996;18:56–72
  19. Brown BA, Wallace RJ Jr, Onyi GO, et al. Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. Antimicrob Agents Chemother 1992;36:180–184.
  20. Tartaglione T . Treatment of nontuberculous mycobacterial infections: role of clarithromycin and azithromycin . Clin Ther . 1997;19:626–638
  21. Watt B , Rayner A , Harris G . Comparative activity of azithromycin against clinical isolates of mycobacteria . J Antimicrob Chemother . 1996;38:539–542

 Supported in part by Research to Prevent Blindness, Inc., New York, NY (G.N.H., B.J.M.), the Jules Stein Eye Institute Card Family Research Fund and Wasserman Fund (B.J.M.), the Skirball Foundation, Los Angeles, CA (G.N.H.), and the David May II Endowed Professorship (G.N.H.). Dr. Holland is a recipient of a Research to Prevent Blindness, Physician-Scientist Award.

PII: S0002-9394(04)00509-4

doi: 10.1016/j.ajo.2004.04.071

American Journal of Ophthalmology
Volume 138, Issue 4 , Pages 547-553 , October 2004